Jon Stanley’s practice involves a variety of corporate and securities matters, including mergers and acquisitions, securities filings, corporate governance, and other transactional matters. Within these fields he serves a broad base of clients, ranging from large private equity firms to founder-owned local businesses. Many of his clients are healthcare companies or companies that serve the healthcare industry, and he is well-versed in the special regulatory issues that these companies face. Jon’s practice includes:
Prior to joining Bass, Berry & Sims, Jon was a shareholder at Harwell Howard Hyne Gabbert & Manner, P.C.
American Health Law Association (AHLA)
Lead Counsel to POINT Biopharma Inc. in connection with its proposed SPAC business combination with Therapeutics Acquisition Corp. d/b/a Research Alliance Corp. I (Nasdaq: RACA), a special purpose acquisition company, sponsored by RA Capital Management. Upon closing, the combined company will be named POINT Biopharma Global Inc. and is expected to be listed on Nasdaq under the ticker symbol “PNT”.
Representation of Healthcare Bluebook in its acquisition of the Quality division of Quantros, Inc., a leading provider of quality analytics software for healthcare providers and payors. Healthcare Bluebook uses industry-leading objective quality and price data and claims-driven ROI reporting to deliver healthcare value insights to consumers, employers, and healthcare providers and payors. Terms of the transaction were not disclosed.
We represented Tractor Supply Company (Nasdaq: TSCO) in their agreement to acquire Orscheln Farm and Home, a family-owned farm and ranch retailer.
We represented Dean Solon, the founder of Shoals Technologies Group, Inc. (backed by Oaktree Capital), a leading solar-power components maker, in connection with Shoals’ initial public offering (IPO) of 88.5 million shares of Class A common stock for a total net proceeds of more than $2.2 billion. The shares began trading on the Nasdaq Global Market under the symbol “SHLS” on January 27, 2021. Bass Berry & Sims has represented Shoals since the 2016 recapitalization transaction with Oaktree Capital.
Representation of Addus HomeCare Corporation (Nasdaq: ADUS), the nation’s largest public provider of personal home care and support services, in its definitive agreement to acquire Queen City Hospice, LLC, and its affiliate Miracle City Hospice, LLC for a cash purchase price of $192.0 million
Representation of Premise Health, the country’s largest direct health care provider and OMERS Private Equity portfolio company, in its acquisition of CareHere, another leading operator of wellness centers for self-funded organizations. The acquisition of CareHere, brings Premise Health’s revenue to approximately $1 billion annually and increases its geographic footprint to more than 850 centers across 45 states and Guam. The combination will allow Premise Health to deliver improved outcomes and enhance health care for employer populations.
Representation of Heritage Global Inc. (Nasdaq: HGBL), an asset services company specializing in financial and industrial assets, in its public offering of 5,462,500 shares of common stock with proceeds of $9,559,375. The underwriters included Lake Street Capital Markets, LLC and Colliers Securities, LLC.
Representation of Synchronous Health, Inc., a behavioral health provider that combines telehealth and artificial intelligence, in its investment from Adventist Health a faith-based, nonprofit integrated health system serving more than 80 communities on the West Coast and Hawaii
Representation of Addus HomeCare Corporation (Nasdaq: ADUS), the nation’s largest public provider of personal home care and support services, in its acquisition of A Plus Health Care, Inc., a provider of home care services, including personal care, private duty nursing, care management and medical staffing
Vanderbilt Law Review — Associate Editor